Antithrombin inhibition using nanobodies to correct bleeding in hemophilia
Abstract In this issue of EMBO Molecular Medicine, Barbon et al describe a new approach to rebalancing coagulation in patients with hemophilia (PWH) through targeted inhibition of anticoagulant antithrombin (AT) (Barbon et al, 2020). In contrast to previous studies that used RNA interference (RNAi)...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer Nature
2020-03-01
|
| Colección: | EMBO Molecular Medicine |
| Acceso en línea: | https://doi.org/10.15252/emmm.202012143 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|